Generation and pharmacological analysis of M 2 and M 4 muscarinic receptor knockout mice

Life Sciences

Volumn 68, Issue 22-23, 2001, Pages 2457-2466

  Gomeza, Jesus ^a   Zhang, Lu ^b   Kostenis, Evi ^a   Felder, Christian C ^b   Bymaster, Frank P ^b   Brodkin, Jesse ^b   Shannon, Harlan ^b   Xia, Bing ^a   Duttaroy, Alokesh ^a   Deng, Chu xia ^a   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Analgesia; Dopamine receptor; Gene targeting; Locomotor activity; Oxotremorine; Parkinson's disease; Striatum

Indexed keywords

CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE; RECEPTOR SUBTYPE;

ANALGESIA; ARTICLE; GENE TARGETING; HYPOTHERMIA; LOCOMOTION; NERVE CELL; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR GENE; RECEPTOR UPREGULATION; STIMULATION; TREMOR;

EID: 0035957547     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01039-6     Document Type: Conference Paper

References (22)

1. Wess J, Buhl T, Lambrecht G, Mutschler E. Cholinergic receptors. In: Emmett JC, editor. Comprehensive Medicinal Chemistry, Vol. 3. Oxford: Pergamon Press, 1990. pp. 423-49.
2. Caulfield MP. Muscarinic receptors - Characterization, coupling and function. Pharmacol. Ther. 1993; 58:319-79.
3. Eglen RM, Choppin A, Dillon MP, Hegde S. Muscarinic receptor ligands and their therapeutic potential. Curr. Opin. Chem. Biol. 1999; 3:426-32.
4. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol. 1996; 10:69-99.
5. Levey AI. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 1993; 52:441-8.
6. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl. Acad. Sci. USA 1997; 94:13311-6.
7. Gomeza J, Shannon H, Kostenis K, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999; 96:1692-7.
8. 4 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999; 96:10483-8.
9. Hartvig P, Gillberg PG, Gordh T, Jr, Post C. Cholinergic mechanisms in pain and analgesia. Trends Pharmacol. Sci. 1989; 10 (Suppl.):75-9.
10. Iwamoto ET, Marion L. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J. Pharmacol. Exp. Ther. 1993; 266:329-38.
11. Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth. Analg. 1997; 85(:847-53.
12. Swedberg MD, Sheardown MJ, Sauerberg P, Olesen PH, Suzdak PD, Hansen KT, Bymaster FP, Ward JS, Mitch CH, Calligaro DO, Delapp NW, Shannon HE. Butylthio[2.2.2] (NNC 11-1053/LY297802): An orally active muscarinic agonist analgesic. J. Pharmacol. Exp. Ther. 1997; 281:876-83.
13. 4 receptor subtype. J. Pharmacol. Exp. Ther. 1999; 288:1143-50.
14. Widman M, Tucker S, Brase DA, Dewey WL. Cholinergic agents: Antinociception without morphine type dependence in rats. Life Sci. 1985; 36:2007-15.
15. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 1996; 383:535-8.
16. Höglund AU, Baghdoyan HA. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. J. Pharmacol. Exp. Ther. 1997; 281:470-7.
17. 4 receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro. J. Pharmacol. Exp. Ther. 2000; 292:877-85.
18. Hersch SM, Gutekunst CA, Rees HD, Heilman CJ, Levey AI. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: Light and electron microscopic immunocytochemistry using subtype-specific antibodies J. Neurosci. 1994; 14:3351-63.
19. Bernard V, Normand E, Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 1992; 12:3591-600.
20. Ince E, Ciliax BJ, Levey AI. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse 1997; 27:357-66.
21. Di Chiara G, Morelli M, Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 1994; 17:228-33.
22. Olianas MC, Adem A, Karlsson E, Onali P. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: Potent block by the selective m4 ligand Muscarinic Toxin 3 (MT3). Br. J. Pharmacol. 1996; 118:283-8.